Published Paper Details:

The field of healthcare analytics has emerged as a transformative discipline that combines data analysis, machine learning, and clinical expertise to improve patient outcomes and optimize the delivery of healthcare services. In recent years, the rapid digitization of healthcare records and the widespread adoption of Electronic Health Records (EHRs) have generated an unprecedented volume of clinical and demographic data. This wealth of data provides an opportunity to move beyond traditional healthcare practices by leveraging computational models for disease prediction, risk assessment, and personalized treatment planning. By integrating machine learning algorithms with clinical knowledge, healthcare analytics enables the extraction of meaningful insights from large datasets, uncovering hidden patterns and relationships that may not be evident through conventional clinical observation. The increasing complexity of patient care, coupled with the growing prevalence of chronic and lifestyle-related diseases, highlights the critical need for predictive models that can assist healthcare professionals in making timely and informed decisions. Traditional healthcare approaches often rely on manual assessment and isolated diagnostic procedures, which can be time-consuming, subjective, and prone to human error. By contrast, machine learning models trained on EHR data can provide automated, accurate, and scalable predictions, helping clinicians identify high-risk patients, anticipate disease progression, and design personalized intervention strategies. This shift towards data-driven decision-making not only enhances the efficiency of healthcare delivery but also enables precision medicine, where treatments and preventive measures are tailored to individual patient profiles, considering factors such as demographics, clinical history, laboratory results, and comorbidities. The primary objective of this research is to develop and evaluate multiple machine learning models for predicting critical health outcomes, specifically focusing on cancer, diabetes, diabetic retinopathy, and heart disease. These conditions are selected due to their high prevalence, significant morbidity and mortality, and potential for early intervention. Using demographic and clinical data obtained from EHRs, the study applies a comparative approach to evaluate the performance of Support Vector Machines (SVM), Decision Trees (DT), Logistic Regression (LR), and Random Forests (RF). By testing these models on diverse datasets, the research aims to determine which algorithms provide the highest accuracy, precision, and recall for each specific disease, thereby assisting clinicians in selecting the most reliable predictive tools for real-world applications. Experimental results indicate promising performance across all selected diseases. Support Vector Machines and Decision Trees achieved exceptional accuracy in predicting cancer (97.08%) and diabetes (97.33%), respectively. For diabetic retinopathy, Logistic Regression demonstrated a notable accuracy of 76.52%, highlighting its effectiveness in structured datasets where linear relationships exist. Heart disease prediction benefited most from Decision Trees, achieving 86.41% accuracy, while SVM applied to the Pima diabetes dataset produced an accuracy of 79.746%. These findings underline the importance of comparative model analysis, as no single algorithm consistently outperforms others across all disease types. By analyzing multiple models, healthcare professionals can identify the optimal approach for each clinical context, improving predictive reliability and supporting evidence-based interventions. Beyond numerical performance metrics, the research emphasizes the practical application of these models in healthcare settings. The system is designed to integrate with clinical workflows, enabling physicians to access risk assessments, visualize patient trends, and receive actionable recommendations. Furthermore, the use of robust evaluation metrics such as accuracy, precision, and recall ensures that predictions are not only statistically sound but also clinically relevant. By bridging the gap between computational modeling and clinical decision-making, this research contributes to enhanced patient care, early diagnosis, and preventive healthcare strategies. In conclusion, this study represents a significant step forward in healthcare analytics by demonstrating the potential of machine learning to transform disease prediction and personalized medicine. By leveraging EHR data and conducting a comparative evaluation of multiple predictive models, the research provides a framework for integrating advanced analytics into routine clinical practice. The high accuracy achieved for critical diseases underscores the feasibility of AI-driven solutions in improving patient outcomes, reducing healthcare costs, and supporting clinicians in making timely, informed decisions. The proposed system lays the foundation for future developments in precision medicine, offering scalable, reliable, and interpretable predictive tools that can adapt to evolving healthcare needs.